Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/9068
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Spyropoulos, Alex C | en_US |
dc.contributor.author | Ageno, Walter | en_US |
dc.contributor.author | Albers, Gregory W | en_US |
dc.contributor.author | Elliott, C Gregory | en_US |
dc.contributor.author | Halperin, Jonathan L | en_US |
dc.contributor.author | Hiatt, William R | en_US |
dc.contributor.author | Maynard, Gregory A | en_US |
dc.contributor.author | Steg, P Gabriel | en_US |
dc.contributor.author | Weitz, Jeffrey I | en_US |
dc.contributor.author | Suh, Eunyoung | en_US |
dc.contributor.author | Spiro, Theodore E | en_US |
dc.contributor.author | Barnathan, Elliot S | en_US |
dc.contributor.author | Raskob, Gary E | en_US |
dc.contributor.author | MARINER Investigators* | en_US |
dc.contributor.author | Kuzmanovska, Biljana | en_US |
dc.date.accessioned | 2020-09-18T09:42:55Z | - |
dc.date.available | 2020-09-18T09:42:55Z | - |
dc.date.issued | 2018-09-20 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/9068 | - |
dc.description.abstract | Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | The New England journal of medicine | en_US |
dc.title | Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1056/NEJMoa1805090 | - |
dc.identifier.volume | 379 | - |
dc.identifier.issue | 12 | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Faculty of Medicine | - |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.